Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

completed375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT

NCT00111228
unknownphase_4

Real-Time Continuous Glucose Monitoring in Pre-School Children With Type-1 Diabetes Mellitus

NCT01016457
completednot_applicable

Effect of Real Time Continuous Glucose Monitoring System on the Management of Type 2 Diabetes

NCT00536549
completed

Investigation of Correlation Between Concentrations of Glucose in Blood and Interstitial Fluid in Type 1 Diabetics

NCT00499954

Clinical Trials (4)

Showing 4 of 4 trials
NCT00111228Not Applicable

The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT

Completed
NCT01016457Phase 4

Real-Time Continuous Glucose Monitoring in Pre-School Children With Type-1 Diabetes Mellitus

Unknown
NCT00536549Not Applicable

Effect of Real Time Continuous Glucose Monitoring System on the Management of Type 2 Diabetes

Completed
NCT00499954

Investigation of Correlation Between Concentrations of Glucose in Blood and Interstitial Fluid in Type 1 Diabetics

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4